Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.21 $286,253 - $514,476
38,946 Added 73.27%
92,098 $676,000
Q1 2023

May 15, 2023

SELL
$7.79 - $16.29 $171,426 - $358,477
-22,006 Reduced 29.28%
53,152 $550,000
Q4 2022

Feb 14, 2023

BUY
$11.0 - $21.45 $826,738 - $1.61 Million
75,158 New
75,158 $887,000
Q1 2022

May 16, 2022

SELL
$36.48 - $52.22 $278,707 - $398,960
-7,640 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$33.11 - $55.01 $252,960 - $420,276
7,640 New
7,640 $332,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.